STOCK TITAN

SRx Health Solutions Redeems Series A Preferred Stock and Cancels Approximately 125,000,000 Shares of Common Stock, Improving Balance Sheet Flexibility for Investment in M&A or Return of Capital to Shareholders

Rhea-AI Impact
(High)
Rhea-AI Sentiment
(Neutral)
Tags

SRx Health Solutions (NYSE:SRXH) redeemed 17,500 shares of its Series A preferred stock on Feb 11, 2026, which represented approximately 125,000,000 common shares on an as-converted basis and were cancelled. The Series A had been sold in a private placement on Oct 31, 2025 for about $15.23 million. The company said the retirement and cancellation improve capital structure flexibility to support future investments or potential returns to shareholders. SRXH also expects to file its Form 10-Q for the quarter ended Dec 31, 2025 on Feb 13, 2026.

Loading...
Loading translation...

Positive

  • Redeemed 17,500 Series A preferred shares, removing ~125,000,000 potential common shares
  • Improves capital structure flexibility for future investments or shareholder returns
  • Private placement raised approximately $15.23 million used in connection with the Series A issuance

Negative

  • No immediate undisclosed M&A plans as of Feb 11, 2026, limiting near-term transaction visibility

News Market Reaction

-16.24% 4.5x vol
18 alerts
-16.24% News Effect
+3.1% Peak Tracked
-32.5% Trough Tracked
-$2M Valuation Impact
$11M Market Cap
4.5x Rel. Volume

On the day this news was published, SRXH declined 16.24%, reflecting a significant negative market reaction. Argus tracked a peak move of +3.1% during that session. Argus tracked a trough of -32.5% from its starting point during tracking. Our momentum scanner triggered 18 alerts that day, indicating notable trading interest and price volatility. This price movement removed approximately $2M from the company's valuation, bringing the market cap to $11M at that time. Trading volume was very high at 4.5x the daily average, suggesting heavy selling pressure.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Series A preferred redeemed: 17,500 shares Common shares cancelled: 125,000,000 shares Preferred issued: 19,035 shares +5 more
8 metrics
Series A preferred redeemed 17,500 shares Redeemed pursuant to Series A terms, tied to common on as-converted basis
Common shares cancelled 125,000,000 shares Approximate common shares on an as-converted basis cancelled via redemption
Preferred issued 19,035 shares Series A Preferred sold in private placement on Oct 31, 2025
Private placement proceeds $15.23 million Aggregate proceeds from Oct 31, 2025 Series A Preferred private placement
Crypto portfolio size $18 million Previously disclosed Bitcoin and Ethereum holdings in treasury strategy
Resale registration (Keystone) 2,506,893,959 shares Common stock registered for resale by Keystone Capital Partners
Equity line capacity $1.0 billion Potential common share sales under equity line of credit structure
Annual net sales $6.5 million Net sales from continuing operations year ended Sep 30, 2025

Market Reality Check

Price: $0.1341 Vol: Volume 48,819,206 vs 20-d...
high vol
$0.1341 Last Close
Volume Volume 48,819,206 vs 20-day average 27,427,275 (relative volume 1.78x), indicating elevated interest ahead of this news. high
Technical Despite the 45.55% move, shares at $0.1601 remain below the $0.41 200-day MA and far under the $2.02 52-week high.

Peers on Argus

SRXH gained 45.55% while key peers showed mixed, generally modest moves, and the...
1 Down

SRXH gained 45.55% while key peers showed mixed, generally modest moves, and the only peer in the momentum scanner (NIVF) moved down. This points to a stock-specific reaction rather than a sector-wide shift.

Historical Context

5 past events · Latest: Feb 06 (Positive)
Pattern 5 events
Date Event Sentiment Move Catalyst
Feb 06 AI product launch Positive -2.3% Launch of EventHorizonIQ ledger for AI-generated financial instability signals.
Feb 03 Crypto risk reduction Positive +5.3% Significant reduction of short positions in Bitcoin and Ethereum portfolio.
Jan 27 Crypto treasury allocation Neutral -2.8% Additional capital allocated to digital assets, bringing holdings to $18M.
Jan 16 Equity investment Neutral -6.6% Investment in Opendoor common stock as part of capital allocation strategy.
Jan 14 Investor event announcement Neutral -6.1% Announcement of virtual fireside chat on EMJX treasury OS strategy.
Pattern Detected

Recent strategic and capital allocation announcements have produced mixed price reactions, with one clear divergence where seemingly positive AI platform news was followed by a price decline.

Recent Company History

Over the past few weeks, SRXH has focused heavily on capital allocation and digital-asset strategy. On Jan 16, it disclosed an equity investment in Opendoor, followed by additional crypto treasury allocation to reach $18 million on Jan 27. It then reduced crypto short exposure on Feb 3 and launched the EventHorizonIQ AI signal ledger on Feb 6. Against this backdrop of financial engineering and digital initiatives, the current preferred stock redemption and common share cancellation further reshape the balance sheet and capital structure.

Market Pulse Summary

The stock dropped -16.2% in the session following this news. A negative reaction despite the redempt...
Analysis

The stock dropped -16.2% in the session following this news. A negative reaction despite the redemption of 17,500 preferred shares and cancellation of roughly 125,000,000 common shares would fit a recent pattern where seemingly constructive strategic moves sometimes coincided with selling. Prior filings documented large registered resale blocks and significant financing structures, which may continue to weigh on sentiment regardless of this action. Historical reactions to AI and digital-asset announcements have also been inconsistent, underscoring ongoing execution and financing risks.

Key Terms

series a preferred stock, private placement, form 10-q, pipe financings, +4 more
8 terms
series a preferred stock financial
"it has redeemed 17,500 shares of its Series A Preferred Stock pursuant"
Series A preferred stock is a type of ownership share in a company that gives investors certain advantages, such as priority in receiving profits or getting their money back if the company is sold or goes bankrupt. It is often issued during early funding stages to attract investors by offering more security than common shares. This stock matters to investors because it provides a safer way to invest while still holding potential for future gains.
private placement financial
"the Company issued and sold in a private placement 19,035 shares"
A private placement is a way for companies to raise money by selling securities directly to a small group of investors instead of through a public offering. This process is often quicker and less regulated, making it similar to offering a special, exclusive investment opportunity to select individuals or institutions. For investors, it can provide access to unique investment options that are not available on public markets.
form 10-q regulatory
"expects to file its Form 10-Q with the SEC for its fiscal first quarter"
A Form 10-Q is a detailed report that publicly traded companies are required to file with regulators three times a year, providing an update on their financial health and business activities. It is important for investors because it offers timely insights into a company's performance, helping them make informed decisions about buying or selling stocks. Think of it as a regular check-up report that shows how well a company is doing.
pipe financings financial
"These shares come from prior PIPE financings in July and October 2025"
PIPE financings are a way for companies to raise money quickly by selling new shares or bonds directly to private investors, instead of through the stock market. This method is often used when companies need cash fast or want to avoid the complexities of public offerings. It matters because it helps companies fund growth or handle financial challenges more efficiently.
equity line of credit financial
"an equity line of credit that may allow sales of up to $1.0 billion"
An equity line of credit is a loan that allows homeowners to borrow money against the value of their property, similar to having a flexible credit card secured by their home. It matters to investors because it provides a way for property owners to access cash for various needs, which can influence real estate markets and overall economic activity. This type of credit offers ongoing borrowing capacity, making it a valuable financial tool for those with significant property equity.
convertible note financial
"and a $20.0 million convertible note tied to that facility"
A convertible note is a type of loan that a company gets from investors, which can later be turned into company shares instead of being paid back in cash. It matters because it helps startups raise money quickly without setting a fixed value for the company right away, making it easier to grow and attract investors.
going concern financial
"auditors have raised substantial doubt about the company’s ability to continue as a going concern"
A going concern is a business that is expected to continue its operations and meet its obligations for the foreseeable future, rather than shutting down or selling off assets. This assumption matters to investors because it indicates stability and ongoing profitability, making the business a more reliable investment. Think of it as believing a restaurant will stay open and serve customers, rather than closing down suddenly.
ccaa restructuring regulatory
"the Canadian subsidiary SRx Canada is in CCAA restructuring with asset sales"
A CCAA restructuring is a court-supervised process under Canada’s Companies’ Creditors Arrangement Act that lets a financially troubled company reorganize its debts and operations instead of being liquidated. For investors, it matters because the process can allow the business to keep operating and preserve or change the value of shares and bonds, but it also brings legal oversight, potential dilution or loss for existing shareholders, and heightened uncertainty until a plan is approved.

AI-generated analysis. Not financial advice.

NORTH PALM BEACH, Fla., Feb. 11, 2026 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the "Company") today announced that it has redeemed 17,500 shares of its Series A Preferred Stock pursuant to the terms of the Series A Preferred Stock, representing approximately 125,000,000 shares of common stock on an as-converted basis. On October 31, 2025 the Company issued and sold in a private placement 19,035 shares of the Series A Preferred Stock for aggregate proceeds of approximately $15.23 million.

The Company expects to file its Form 10-Q with the SEC for its fiscal first quarter for the period ended December 31, 2025 on Friday, February 13, 2026.

Michael Young, Board Member of SRx Health, commented, “The retirement of the preferred and cancellation of approximately 125,000,000 shares of common stock allows for further flexibility of our capital structure for additional investments in the future.”

SRXH does not have immediate plans for M&A as of the date of this release that has not been already disclosed, but will continue to evaluate opportunities from time to time.

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “believe,” “expect,” “intend,” “aim,” “plan,” “may,” “could,” “target,” and similar expressions are intended to identify forward-looking statements. These statements are based on current expectations and assumptions that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied. These risks include, but are not limited to, the ability to complete the proposed transaction, shareholder approvals, market conditions, regulatory considerations, and other risks described in the Company’s filings with the Securities and Exchange Commission. Forward-looking statements speak only as of the date made, and the Company undertakes no obligation to update them, except as required by law.

Company Contact
SRx Health Solutions, Inc.
Kent Cunningham, Chief Executive Officer

Investor Relations Contact
KCSA Strategic Communications
Valter Pinto, Managing Director
212-896-1254
valter@kcsa.com

Media Contact
KCSA Strategic Communications
Kristin Cwalinski, Senior Vice President
EMJX@KCSA.com


FAQ

What did SRXH announce about the Series A preferred redemption on Feb 11, 2026?

SRXH redeemed 17,500 Series A preferred shares, which converted to about 125,000,000 common shares that were cancelled. According to the company, the redemption follows a private placement and is intended to improve capital structure flexibility for future investments or shareholder returns.

How many common shares were cancelled by SRXH and what is the impact for shareholders?

About 125,000,000 common-share equivalents were cancelled after the preferred redemption, reducing potential dilution. According to the company, this cancellation increases flexibility in capital allocation and could support future M&A or return-of-capital decisions.

Did SRXH raise cash related to the Series A preferred issuance and how much was raised?

SRXH previously sold 19,035 Series A preferred shares in a private placement for roughly $15.23 million on Oct 31, 2025. According to the company, that private placement was the source of proceeds associated with the Series A issuance and subsequent redemption.

When will SRXH file its Form 10-Q for the quarter ended Dec 31, 2025?

SRXH expects to file its Form 10-Q for the fiscal quarter ended Dec 31, 2025 on Feb 13, 2026. According to the company, the filing timing is planned and may provide additional financial detail related to the redemption and quarter-end results.
SRX Health Solutions Inc

NYSE:SRXH

SRXH Rankings

SRXH Latest News

SRXH Latest SEC Filings

SRXH Stock Data

10.33M
69.56M
Medical Care Facilities
Beverages
Link
Canada
NORTH PALM BEACH